FierceBiotech

The FDA has rejected Biohaven’s…

news2025-11-05T04:04:00+00:00November 5th, 2025|FierceBiotech|

Following a middling phase 3…

news2025-11-04T17:41:00+00:00November 4th, 2025|FierceBiotech|

Less than two years after…

news2025-11-04T17:22:00+00:00November 4th, 2025|FierceBiotech|

The…

news2025-11-04T16:42:00+00:00November 4th, 2025|FierceBiotech|

Protara is working to address…

news2025-11-04T14:49:00+00:00November 4th, 2025|FierceBiotech|

Eli Lilly is doubling down on its…

news2025-11-04T14:29:00+00:00November 4th, 2025|FierceBiotech|

Pfizer has axed 11 programs…

news2025-11-04T13:58:00+00:00November 4th, 2025|FierceBiotech|

Fueled by public-private…

news2025-11-04T12:04:00+00:00November 4th, 2025|FierceBiotech|

Questex has acquired The…

news2025-11-04T12:00:00+00:00November 4th, 2025|FierceBiotech|

As deal-making rebounds in a…

news2025-11-04T11:32:00+00:00November 4th, 2025|FierceBiotech|

Previous131415Next